The use of cilostazol for secondary stroke prevention: isn’t it time it’s evaluated in Western countries?-Reference-Cited by-同舟云学术

The use of cilostazol for secondary stroke prevention: isn’t it time it’s evaluated in Western countries?

Published:2020-01-14 Issue:4 Volume:21 Page:381-387
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Di Napoli Mario¹²,Singh Puneetpal³,Lattanzi Simona⁴,Divani Afshin A.⁵

Affiliation:

1. Department of Neurology and Stroke Unit, San Camillo de’ Lellis General Hospital, Rieti, Italy

2. Neurological Section, Neuro-epidemiology Unit, SMDN, Centre for Cardiovascular Medicine and Cerebrovascular Disease Prevention, Sulmona, L’Aquila, Italy

3. Division of Molecular Genetics, Department of Human Genetics, Punjabi University, Patiala, India

4. Neurological Clinic, Department of Experimental and Clinical Medicine, Marche Polytechnic University, Ancona, Italy

5. Department of Neurology, University of New Mexico, Albuquerque, NM, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2019.1707181

Reference43 articles.

1. Cyclic nucleotide phosphodiesterase (PDE) superfamily: A new target for the development of specific therapeutic agents

2. Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial

3. Cilostazol Prevents the Progression of the Symptomatic Intracranial Arterial Stenosis

4. Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study

5. Cilostazol for treatment of cerebral infarction

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contemporary Antiplatelet and Anticoagulant Therapies for Secondary Stroke Prevention: A Narrative Review of Current Literature and Guidelines;Current Neurology and Neuroscience Reports;2023-04-11

2. Cilostazol-imprinted polymer film-coated electrode as an electrochemical chemosensor for selective determination of cilostazol and its active primary metabolite;Journal of Materials Chemistry B;2022

3. Antiplatelet Therapy in the Secondary Prevention of Non-cardioembolic Ischemic Stroke and Transient Ischemic Attack: A Mini-Review;Frontiers in Neurology;2021-02-25

4. Cilostazol reduces cerebrovascular risk through the inhibition of multi-drug resistance protein 4/ATP binding cassette subfamily C member 4;Expert Opinion on Pharmacotherapy;2020-04-28